← Leaderboards
Howland Crosswell
Kiyatec, Inc.
$1,975,209
Attributed
$1,975,209
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,975,209 · 1
By mechanism
N44$1,975,209 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antineoplastic Agents”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,409,738
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Gregory H Reaman · National Childhood Cancer Foundation$94,722,934
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Walter John Curran · Thomas Jefferson University$55,187,978
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
Research focus
Antineoplastic AgentsBaseBasic ScienceBiological MarkersBreastBreast Cancer ModelCell LineCisplatinClinical Decision-MakingClinical TrialsDatabasesDissectionDrug DevelopmentEndothelial CellsEpigenetic ProcessEpigenomicsEstablished Cell LineFailure (Biologic Function)Fda ApprovedGene ExpressionGenerationsGeneticGenomicsAngiogenesis